Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Mixed-Methods Feasibility Study to Evaluate the Agreement, Safety, and Acceptability of 'Dora Care', an Automated AI Voice Assistant, for Supporting Clinical Pathways in a Fracture Liaison Service.

NCT07464171 is registered in ClinicalTrials.gov with Ufonia as lead sponsor.

NCT NCT07464171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07464171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Mixed-Methods Feasibility Study to Evaluate the Agreement, Safety, and Acceptability of 'Dora Care', an Automated AI Voice Assistant, for Supporting Clinical Pathways in a Fracture Liaison Service.
Lead sponsor
Ufonia
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
December 31, 2027
Enrollment
217 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ai (artificial intelligence), automation, bone health, osteoporosis, outpatient, risk assesment, telemedicine